Clinical pharmacology study of calcium alginate capsules -optimization study of inhibition of postprandial blood glucose level elevation
Not Applicable
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000048540
- Lead Sponsor
- Takasaki University of Health and Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
1.Persons whose BMI and body weight do not fit into the normal distribution (95% confidence interval) 2.Persons taking medicines or supplements that may affect glucose metabolism 3.Persons who are currently being treated for diabetes or who are judged to need treatment 4.Persons with serious diseases such as diabetes, liver disease, renal disease, hypertension, ischemic heart disease, digestive system disease, and those with a history of them 5.Persons who may cause allergic symptoms regarding udon noodles (flour, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method